Daphne Lainson profiled in Managing IP

Daphne Lainson, principal and leader of the Life Sciences and Bio/Chem practice group recently shared her unique perspective on navigating complex patent landscapes and her commitment to helping clients protect and maximize their intellectual assets in an interview with Managing IP (MIP).

Daphne’s deep understanding of the intersection between technology and IP law is driving significant value for her clients. The most exciting part of her role is making a tangible impact by helping clients navigate complex issues and successfully bring lifesaving or life-changing drugs to Canada.

Her innovative approach and strategic expertise in intellectual property law are setting benchmarks in the industry.

Read the full article on MIP.